[PDF] Top 20 J. Bras. Nefrol. vol.34 número4 en v34n4a03
Has 10000 "J. Bras. Nefrol. vol.34 número4 en v34n4a03" found on our website. Below are the top 20 most common "J. Bras. Nefrol. vol.34 número4 en v34n4a03".
J. Bras. Nefrol. vol.34 número4 en v34n4a03
... This was a randomized clinical trial conducted on 20 (58.8%) of the 34 diabetic patients being managed at the ULBRA Hemodialysis Unit. The following were the inclusion/exclusion criteria: age, minimum 18 years; ... See full document
5
J. Bras. Nefrol. vol.34 número1 en a11v34n1
... This study aimed to assess the impact of demo- graphic, clinical and laboratory variables that were present at admission and let to the outcomes death or renal re[r] ... See full document
8
J. Bras. Nefrol. vol.34 número1 en a01v34n1
... These include de- monstrably successful models of kidney transplant programs in many developing countries; growing availability of less expensive generic immunosuppres- siv[r] ... See full document
7
J. Bras. Nefrol. vol.34 número1 en a02v34n1
... Methods: Symptomatic patients, patients with ischemia on myocar- dial scintigraphy and/or systolic dysfunc- tion on echocardiography, patients older than 50 years and diabetes[r] ... See full document
8
J. Bras. Nefrol. vol.34 número1 en a04v34n1
... Therefore, the purpose of this study was to com- pare Kt/V results obtained with Lowrie`s formula (L Kt/V) with those obtained with Daugirdas`s for- mula (D Kt/V), and the latter [r] ... See full document
5
J. Bras. Nefrol. vol.34 número1 en a05v34n1
... Introdução: A albumina pré-diálise pode ter sua utilidade questionada na avaliação do estado proteico devido ao efeito dilu- cional nesse período. Objetivos: Avaliar se a albumina sérica dosada no período pós-diálise ... See full document
9
J. Bras. Nefrol. vol.34 número1 en a07v34n1
... Introduction: One of the biggest chal- lenges in the management of hyperten- sion is adequate blood pressure (BP) control. To achieve this goal, home blood pressure measurement (HBPM) with automated devices has been ... See full document
7
J. Bras. Nefrol. vol.34 número1 en a09v34n1
... Therapy with ergocalciferol or colecalciferol in pa- tients with CKD with 25(OH)D deficiency has been little described in literature, thus showing it is associ- ated with high serum lev[r] ... See full document
6
J. Bras. Nefrol. vol.34 número1 en a14v34n1
... Because of the index case and the parents` consangui- nity, we raised the possibility of BS in the girl`s older and only sister. This second girl had also been pre- maturely born, after a polyhydramnios-complicated ... See full document
5
J. Bras. Nefrol. vol.34 número3 en v34n3a06
... Translation, cultural adaptation, and validation of the Screening For Occult Renal Disease (SCORED) questionnaire to Brazilian Portuguese.. A BSTRACT.[r] ... See full document
8
J. Bras. Nefrol. vol.34 número1 en a16v34n1
... 16. Lang RM, Bierig M, Devereux RB, flachskampf fA, foster e, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of echocardiography’s Guidelines and Standards Committee ... See full document
6
J. Bras. Nefrol. vol.34 número2
... Our study has several limitations. First and fore- most, it was not placebo-controlled. Other studies in the field indicate minimal effects from placebo, so we believed it was not necessary to have a placebo group in our ... See full document
5
J. Bras. Nefrol. vol.34 número2
... lação hepática, são convertidas em 25-vit D. A 25-vit D representa o estoque corporal de vi- tamina D e não deve ser confundida com calcitriol (1,25-vit D) que é um hormônio sintetizado princi- palmente nos rins. ... See full document
7
J. Bras. Nefrol. vol.34 número1
... contribute to it. Therefore, angiotensin converting en- zyme inhibitor and thiazides could be useful to these patients. Our aim is to report the effects of enalapril and hydrochlorothiazide (HCTZ) in two novel ... See full document
4
J. Bras. Nefrol. vol.32 número4 en v32n4a01
... The winner of the Heonir Rocha award 2010 was the article: “Prothrombin G20210A gene mutation, factor V Leiden and anti- cardiolipin antibodies do not influence renal graft survival aft[r] ... See full document
2
J. Bras. Nefrol. vol.32 número4 en v32n4a02
... The results have shown that HCV infection did not influence negatively the survival of our patients undergoing chronic HD, as described in pre- vious studies 7,10,16 , and, paradoxical[r] ... See full document
5
J. Bras. Nefrol. vol.32 número4 en v32n4a03
... Situations with indications for techniques to enhance elimination include the following: poisoning with a substance whose elimi- nation is known to be increased by use of a certain te[r] ... See full document
9
J. Bras. Nefrol. vol.34 número3 en v34n3a08
... 2. European Society of Hypertension-European Society of Cardio- logy Guidelines Committee. 2003 European Society of Hyper- tension-European Society of Cardiology guidelines for the mana- gement of arterial hypertension. ... See full document
6
J. Bras. Nefrol. vol.34 número3 en v34n3a05
... Based on these data, the objectives of the present research were as follows: (1) identify and characterize, clinically and epidemiologically, hypertensive patients who had renal arter[r] ... See full document
8
J. Bras. Nefrol. vol.34 número4
... 18. Okada H, BanS, Nagao S, Takahashi H, Suzuki H, Neilson EG. Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int 2000;58:587-97. 19. Tian YC, Fraser D, ... See full document
6
temas relacionados